Health Advisory: Disruptions in Availability of Products from Baxter International

Act now to mitigate impact on patient care

CDC Health Advisory: Disruptions in Availability of Peritoneal Dialysis and Intravenous Solutions from Baxter International Facility in North Carolina

CDC is issuing this Health Alert Network (HAN) Health Advisory to inform healthcare providers, pharmacists, healthcare facility administrators, and state, tribal, local, and territorial health departments of a supply disruption of peritoneal dialysis (PD) and intravenous (IV) solutions from the Baxter International’s plant in North Carolina, due to Hurricane Helene.

The supply disruption could impact patient care and require adjustments to the clinical management of patients. Healthcare providers, pharmacists, healthcare facility administrators—regardless of supply chain disruptions—should immediately assess their supply and develop plans and mitigation strategies to reduce the potential impact on patient care. A disruption in the availability of these products can affect optimal patient care. Facilities can implement strategies to conserve their fluid supplies and avoid waste early to reduce the impact on services.

	CDC is alerting healthcare providers, pharmacists, facility administrators, and health departments of a supply disruption peritoneal dialysis (PD) and intravenous (IV) solutions from the Baxter plant in North Carolina, due to Hurricane Helene. Learn more: https://bit.ly/3U6XtpC

Centers for Disease Control and Prevention 1600 Clifton Rd   Atlanta, GA 30329   1-800-CDC-INFO (800-232-4636)   TTY: 888-232-6348 Questions or Problems  |  Unsubscribe